Literature DB >> 20109598

Myocarditis.

Lori A Blauwet1, Leslie T Cooper.   

Abstract

Myocarditis is an uncommon, potentially life-threatening disease that presents with a wide range of symptoms in children and adults. Viral infection is the most common cause of myocarditis in developed countries, but other etiologies include bacterial and protozoal infections, toxins, drug reactions, autoimmune diseases, giant cell myocarditis, and sarcoidosis. Acute injury leads to myocyte damage, which in turn activates the innate and humeral immune system, leading to severe inflammation. In most patients, the immune reaction is eventually down-regulated and the myocardium recovers. In select cases, however, persistent myocardial inflammation leads to ongoing myocyte damage and relentless symptomatic heart failure or even death. The diagnosis is usually made based on clinical presentation and noninvasive imaging findings. Most patients respond well to standard heart failure therapy, although in severe cases, mechanical circulatory support or heart transplantation is indicated. Prognosis in acute myocarditis is generally good except in patients with giant cell myocarditis. Persistent, chronic myocarditis usually has a progressive course but may respond to immunosuppression.

Entities:  

Mesh:

Year:  2010        PMID: 20109598      PMCID: PMC5951175          DOI: 10.1016/j.pcad.2009.11.006

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  186 in total

1.  Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results.

Authors:  R Wojnicz; E Nowalany-Kozielska; C Wojciechowska; G Glanowska; P Wilczewski; T Niklewski; M Zembala; L Polonski; M M Rozek; J Wodniecki
Journal:  Circulation       Date:  2001-07-03       Impact factor: 29.690

2.  Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.

Authors:  M S Horwitz; A La Cava; C Fine; E Rodriguez; A Ilic; N Sarvetnick
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

3.  Incidence, causes, and outcomes of dilated cardiomyopathy in children.

Authors:  Jeffrey A Towbin; April M Lowe; Steven D Colan; Lynn A Sleeper; E John Orav; Sarah Clunie; Jane Messere; Gerald F Cox; Paul R Lurie; Daphne Hsu; Charles Canter; James D Wilkinson; Steven E Lipshultz
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

4.  Echocardiographic findings in myocarditis.

Authors:  B Pinamonti; E Alberti; A Cigalotto; L Dreas; A Salvi; F Silvestri; F Camerini
Journal:  Am J Cardiol       Date:  1988-08-01       Impact factor: 2.778

5.  Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes.

Authors:  D C Lyden; J Olszewski; M Feran; L P Job; S A Huber
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

6.  Myocardial expression of fas and recovery of left ventricular function in patients with recent-onset cardiomyopathy.

Authors:  Richard Sheppard; Maninder Bedi; Toru Kubota; Marc J Semigran; William Dec; Richard Holubkov; Arthur M Feldman; Warren D Rosenblum; Charles F McTiernan; Dennis M McNamara
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

7.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

8.  Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy.

Authors:  M Giulia Gagliardi; M Bevilacqua; C Bassano; B Leonardi; R Boldrini; F Diomedi Camassei; A Fierabracci; A G Ugazio; G F Bottazzo
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

9.  Pathology of the heart in acquired immunodeficiency syndrome.

Authors:  D N Lanjewar; G A Katdare; P P Jain; S K Hira
Journal:  Indian Heart J       Date:  1998 May-Jun

10.  Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization.

Authors:  T J Wickham; E J Filardo; D A Cheresh; G R Nemerow
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

View more
  109 in total

1.  PR depression is useful in the differential diagnosis of myopericarditis and ST elevation myocardial infarction.

Authors:  Pekka Porela; Ville Kytö; Kjell Nikus; Markku Eskola; K E J Airaksinen
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-04       Impact factor: 1.468

2.  NF-κB activation is cell type-specific in the heart.

Authors:  Efraín E Rivera-Serrano; Barbara Sherry
Journal:  Virology       Date:  2016-12-30       Impact factor: 3.616

Review 3.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

Review 4.  Immune modulation in heart failure: past challenges and future hopes.

Authors:  Jose H Flores-Arredondo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Heart Fail Rep       Date:  2011-03

5.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

Review 6.  Role of endomyocardial biopsy for children presenting with acute systolic heart failure.

Authors:  Bibhuti B Das
Journal:  Pediatr Cardiol       Date:  2013-11-09       Impact factor: 1.655

7.  TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.

Authors:  Eric D Abston; Michael J Coronado; Adriana Bucek; Jennifer A Onyimba; Jessica E Brandt; J Augusto Frisancho; Eunyong Kim; Djahida Bedja; Yoon-kyu Sung; Andrea J Radtke; Kathleen L Gabrielson; Wayne Mitzner; DeLisa Fairweather
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-12-19       Impact factor: 3.619

Review 8.  Recent advances of adapter proteins in the regulation of heart diseases.

Authors:  Li Tao; Linna Jia; Yuntian Li; Chengyun Song; Zheng Chen
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

9.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

10.  Republished: pathogenesis and diagnosis of myocarditis.

Authors:  Chantal Elamm; Delisa Fairweather; Leslie T Cooper
Journal:  Postgrad Med J       Date:  2012-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.